In the context of tumor glycolysis, preclinical evidence suggests that endurance training decreases expression of monocarboxylate transporter 1 (MCT1) and LDH-A while concomitantly increases LDH-B in breast tumors [29]. This evidence concerns the gene SLC16A1 and breast neoplasm.